LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)

Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Trametinib
0.00021667
25.79 27.76 2108 1605 1.3133 1.0953
MN20160318_Q01
N10
MCF 10A-H2B-mCherry Trametinib
0.00021667
25.79 27.76 65 1605 0.0405 0.1565
MN20160318_Q01
N21
MCF 10A-H2B-mCherry Trametinib
0.00021667
25.79 27.76 1912 1605 1.1912 1.0607
MN20160318_Q01
N21
MCF 10A-H2B-mCherry Trametinib
0.00021667
27.49 27.76 108 1723 0.0627 0.2562
MN20160318_Q01
G22
MCF 10A-H2B-mCherry Trametinib
0.00021667
27.49 27.76 1858 1723 1.0783 1.0255
MN20160318_Q01
G22
MCF 10A-H2B-mCherry Trametinib
0.00021667
27.49 27.76 132 1723 0.0766 0.2993
MN20160318_Q01
J19
MCF 10A-H2B-mCherry Trametinib
0.00021667
27.49 27.76 2352 1723 1.3649 1.1072
MN20160318_Q01
J19
MCF 10A-H2B-mCherry Trametinib
0.00021667
27.49 27.76 2134 1723 1.2384 1.0731
MN20160318_Q01
N10
MCF 10A-H2B-mCherry Trametinib
0.00021667
27.49 27.76 2265 1723 1.3145 1.0940
MN20160318_Q01
N10
MCF 10A-H2B-mCherry Trametinib
0.00021667
27.49 27.76 67 1723 0.0389 0.1595
MN20160318_Q01
N21
MCF 10A-H2B-mCherry Trametinib
0.00021667
27.49 27.76 2013 1723 1.1682 1.0529
MN20160318_Q01
N21
MCF 10A-H2B-mCherry Trametinib
0.00021667
29.19 27.76 134 1863 0.0719 0.2962
MN20160318_Q01
G22
MCF 10A-H2B-mCherry Trametinib
0.00021667
29.19 27.76 1981 1863 1.0633 1.0203
MN20160318_Q01
G22
MCF 10A-H2B-mCherry Trametinib
0.00021667
29.19 27.76 142 1863 0.0762 0.3086
MN20160318_Q01
J19
MCF 10A-H2B-mCherry Trametinib
0.00021667
29.19 27.76 2517 1863 1.3509 1.1016
MN20160318_Q01
J19
MCF 10A-H2B-mCherry Trametinib
0.00021667
29.19 27.76 2286 1863 1.2270 1.0686
MN20160318_Q01
N10
MCF 10A-H2B-mCherry Trametinib
0.00021667
29.19 27.76 2433 1863 1.3059 1.0899
MN20160318_Q01
N10
MCF 10A-H2B-mCherry Trametinib
0.00021667
29.19 27.76 77 1863 0.0413 0.1831
MN20160318_Q01
N21
MCF 10A-H2B-mCherry Trametinib
0.00021667
29.19 27.76 2239 1863 1.2017 1.0615
MN20160318_Q01
N21
MCF 10A-H2B-mCherry Trametinib
0.00021667
30.90 27.76 191 2032 0.0940 0.3653
MN20160318_Q01
G22
MCF 10A-H2B-mCherry Trametinib
0.00021667
30.90 27.76 2096 2032 1.0313 1.0100
MN20160318_Q01
G22
MCF 10A-H2B-mCherry Trametinib
0.00021667
30.90 27.76 150 2032 0.0738 0.3131
MN20160318_Q01
J19
MCF 10A-H2B-mCherry Trametinib
0.00021667
30.90 27.76 2776 2032 1.3659 1.1033
MN20160318_Q01
J19
MCF 10A-H2B-mCherry Trametinib
0.00021667
30.90 27.76 2502 2032 1.2311 1.0683
MN20160318_Q01
N10
MCF 10A-H2B-mCherry Trametinib
0.00021667
30.90 27.76 2612 2032 1.2852 1.0827
MN20160318_Q01
N10